Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 15058628

Defibrillators.

View original source ↗Export metadata ↓

Abstract

Sudden cardiac arrest can strike anyone, anywhere and at any time, often without warning. Reported survival rates for cardiac arrest with ventricular fibrillation are low: from 3 to 10 percent. Studies have shown that rapid defibrillation after out-of-hospital cardiac arrest with ventricular fibrillation is the most important determinant of survival. That is why training people to use automated external defibrillators, or AEDs, in public places can double the odds that a person in cardiac arrest will survive. The ADA recently awarded the Seal of Acceptance to HeartStart OnSite and FR2+ defibrillators. HeartStart defibrillators are easy to use. HeartStart defibrillators are designed specifically for the lay responder. They provide clear, easy-to-follow voice instructions and a simple user interface to guide the responder through an emergency reliable. HeartStart defibrillators perform comprehensive daily, weekly and monthly self-tests to help ensure readiness. A highly visible status indicator shows at a glance that the device is ready for use safe. HeartStart defibrillators have an innovative design that makes it virtually impossible to shock someone who is not in cardiac arrest. The heart rhythm first is analyzed to ensure that a shock is needed. The device will not allow the user to deliver a shock that the analysis determines is unnecessary. Philips offers two defibrillator models for the dental office: the HeartStart OnSite Defibrillator and the HeartStart FR2+ Defibrillator. The HeartStart OnSite Defibrillator is intended to be easy to use for responders in an office setting. It provides step-by-step verbal instructions on how to perform cardiopulmonary resuscitation, or CPR. The HeartStart FR2+ Defibrillator is designed for first responders, such as flight attendants, nurses, police officers and designated workplace responders who participate in regular training. Each HeartStart defibrillator comes with a nonrechargeable long-life battery, two sets of adult pads and complete instructions for use.

Explore related subjects

Advanced Cardiac Life SupportElectric CountershockHeart ArrestHumansJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

2004. Defibrillators.. https://doi.org/10.14219/jada.archive.2004.0189

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2004

Stability of advanced life support drugs in the field.

PURPOSE: The effects of wide temperature variations on the stability of atropine, epinephrine, and lidocaine stored under field conditions in advanced life support (ALS) paramedic units were evaluated. METHODS: Vehicles from various ALS paramedic units were selected throughout Los Angeles County, California, including desert, marine, and helicopter-based divisions. A temperature-recording device was placed in the compartment where drugs are stored and used to record and store temperature data at 15-minute intervals. Three autoinjector-style syringes of atropine, epinephrine, and lidocaine were taken from stock for each ALS unit and placed in each vehicle, while three control syringes were stored in the laboratory under controlled conditions. Six samples of each drug were withdrawn at time 0 and on days 5, 10, 15, 30, and 45. Samples were analyzed using high-performance liquid chromatography. Stock solutions, created using analytical grade atropine, epinephrine, and lidocaine, were used to construct 5-point standard curves to determine the drug concentration of each sample. RESULTS: Seven sites exceeded 104 degrees F (40 degrees C) for as little as 30 minutes and as long as 795 minutes. Ten of the sites achieved a mean kinetic temperature (MKT) above 77 degrees F (25 degrees C), with the highest MKT calculated being 84.1 degrees F (28.9 degrees C) over a 45-day period. There was no evidence of drug degradation at any site, at any temperature, or at any time point. CONCLUSION: Atropine, epinephrine, and lidocaine can be stored at temperatures of up to 84.1 degrees F (28.9 degrees C) for up to 45 days and tolerate temperature spikes of up to 125 degrees F (51.7 degrees C) for a cumulative time of 795 minutes (13.25 hours) without undergoing degradation.

Advanced Cardiac Life Support↗